Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety.
Autor: | Bernhard, Wendy1 (AUTHOR), Barreto, Kris1 (AUTHOR), El-Sayed, Ayman1 (AUTHOR), Gonzalez, Carolina1 (AUTHOR), Viswas, Raja Solomon2 (AUTHOR), Toledo, Darien3 (AUTHOR), Casaco, Angel3 (AUTHOR), DeCoteau, John1 (AUTHOR), Fonge, Humphrey2,4 (AUTHOR) humphrey.fonge@usask.ca, Geyer, Clarence Ronald1 (AUTHOR) ron.geyer@usask.ca |
---|---|
Zdroj: | BMC Cancer. 3/12/2021, Vol. 21 Issue 1, p1-13. 13p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |